Rock Edwin 4
4 · GLYCOMIMETICS INC · Filed Jun 24, 2024
Insider Transaction Report
Form 4
Rock Edwin
Chief Medical Officer
Transactions
- Purchase
Common Stock
2024-06-20$0.25/sh+190,000$48,108→ 565,403 total - Purchase
Common Stock
2024-06-21$0.27/sh+115,000$30,717→ 680,403 total
Footnotes (2)
- [F1]The Reporting Person purchased the securities on the open market at purchase prices ranging from $0.24 to $0.2594 per share, with a weighted average purchase price of $0.2532 per share. The Reporting Person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
- [F2]The Reporting Person purchased the securities on the open market at purchase prices ranging from $0.2579 to $0.27 per share, with a weighted average purchase price of $0.2671 per share. The Reporting Person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.